Jacqualyn A. Fouse

2014 - Celgene

In 2014, Jacqualyn A. Fouse earned a total compensation of $8.7M as President Hematology and Oncology at Celgene, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$4,867,123
Option Awards$2,077,620
Salary$803,250
Stock Awards$901,257
Other$22,238
Total$8,671,488

Fouse received $4.9M in non-equity incentive plan, accounting for 56% of the total pay in 2014.

Fouse also received $2.1M in option awards, $803.3K in salary, $901.3K in stock awards and $22.2K in other compensation.

Rankings

In 2014, Jacqualyn A. Fouse's compensation ranked 672nd out of 13,032 executives tracked by ExecPay. In other words, Fouse earned more than 94.8% of executives.

ClassificationRankingPercentile
All
672
out of 13,032
95th
Division
Manufacturing
242
out of 4,966
95th
Major group
Chemicals And Allied Products
76
out of 1,686
96th
Industry group
Drugs
58
out of 1,365
96th
Industry
Pharmaceutical Preparations
55
out of 1,043
95th
Source: SEC filing on April 28, 2016.

Fouse's colleagues

We found six more compensation records of executives who worked with Jacqualyn A. Fouse at Celgene in 2014.

2014

Robert Hugin

Celgene

Chief Executive Officer

2014

Peter Kellogg

Celgene

Chief Financial Officer

2014

Mark Alles

Celgene

Chief Operating Officer

2014

Thomas Daniel

Celgene

Chairman

2014

Perry Karsen

Celgene

Chief Executive Officer

2014

Scott Smith

Celgene

President, Immunology & Inflammation

News

You may also like